We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
A strong opening in USA . One day news may appear. Best of Luck All
News may well be good. Best of Luck All
when is the next piece of news due - surely if 2018 is as good as expected, this should hit 30 mill mcap at least - that's 100 p ?? right?
Very quiet here as well.
A big very quick dip.
2% drop but post market 4% increase
What’s happening on Nasdaq. A huge shake -17%
Top of the leader board. Up at least two days in a row. Whatever the reason.
Back to 25%. Looks like they don`t want buyers. Best of Luck All
Up up and away!!
Why a huge spread?
Should be the end of today`s fun. Best of Luck All
Should take Akers to around the �1 mark . Then Yiangos you may take your profit & buy Me . Consequently ,�1 may not be our zenith ( to be discussed) . Best of Luck All
Some early doors, FDA approva �2.00 easy!
Back to 25%. Looks like they don`t want buyers. Best of Luck All
More to come this week . Especially if the much vaunted good news arrives. Best of Luck All
70 cents = 44p Best of Luck All Disappeared from the top Board ??
Actually sold half my holding in these a while back to buy online b. Could've been a mistake.
Maybe, For Akers Biosciences Inc (LON:AKR, NASDAQ:AKER), 2018 will be a defining year, according to chief executive John Gormally and its founder Raymond Akers. For having secured US$6.9mln of new investment, the company is focused on becoming cash flow positive and profitable. READ: Akers Biosciences unveils plans to raise US$6mln The turnaround probably can�t come quickly enough for shareholders in a business currently valued at less than the cash it has in the bank. A rerating will be effected if the company can successfully deliver on its fully-funded growth strategy set out in a 21-page Powerpoint presentation the firm delivered to would-be investors ahead of its most recent fund-raiser. Host of other products The cornerstone of the business will continue to be the PIFA rapid assay for an allergy to the blood thinner heparin; however, there�s a host of other products that it is hoped will help propel the company towards profitability. Chief among them is a new rapid test for Chlamydia that has huge potential: the PIFA PLUSS assay, which can deliver results in five minutes rather than the days it takes for a lab test. For women, at least, the simple blood test is far less invasive than the cervical swab currently used to collect samples. �This product, we believe, is going to be transformational for the company,� says its chairman Akers. �There is nothing like it in the world. It is the first assay that gives you the results in minutes and it is also the first blood test for Chlamydia.� It aims to work with the organisation Planned Parenthood in the US where it will also target clinics, college campus medical centres alongside government care-givers. Potential commercial partners CEO Gormally said executives are lining up potential commercial partners who would help introduce PIFA PLUSS Chlamydia to the wider world; however, the product must first receive what�s called 510(k) approval from the US Food & Drug Administration. The process of securing this regulatory sign-off began last May and the medicines watchdog asked for more data from Akers in December. �We are nearer the end of the road with the FDA but it is very difficult to predict when it is going to happen. We think it is going to be sooner rather than later,� said Akers. The story doesn�t end with Chlamydia. The company�s health and wellness offering also has the potential to generate significant revenues, Gormally points out. Akers has developed an app that helps users track their health over time, which segues nicely with a number of products that tap into huge markets. It has breath test devices that help promote, track and encourage choices related to general health and wellbeing. Talking to network marketing companies It is talking to network marketing companies in a bid to open new sales channels, and the plan is to target weight loss centres, h
What news. Transformational?
With luck good news from FDA
Why the super rise.? And so late?
Well done Krispy. Happy hols . With luck good news from FDA and over �1 per share whilst you have fun in the snow .
Should mean 40p plus . Best of Luck All
Tiny spread . This usually has a spread of 20% ++ Best of Looks like 41p today